In The Oncologist, Wilson et al reported the prognostic value of circulating tumor DNA (ctDNA) sequencing in head and neck squamous cell carcinoma (HNSCC) for the first time.1 Of interest, TP53 was the most altered gene (73.3%) and the most concordant gene in ctDNA and tDNA. This evidence concerns the gene TP53 and neoplasm.